TCI Gene Inc. (6879) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for TCI Gene Inc. (6879:TWSE), powered by AI.

Current Price
$37.00
Sector
Healthcare
What is the TCI Gene Inc. stock price forecast?

TCI Gene Inc. is currently trading at $37.00. View real-time AI analysis on Alpha Lenz.

What is TCI Gene Inc. insider trading activity?

View the latest insider trading data for TCI Gene Inc. on Alpha Lenz.

What is TCI Gene Inc.'s P/E ratio?

View TCI Gene Inc.'s valuation metrics on Alpha Lenz.

TCI Gene Inc.

TWSE · 6879
NT$37.00+1.30(+3.64%)
Ask about TCI Gene Inc.'s future dividend policy...
Alpha Chat Insight

TCI Gene Inc.'s ROE is 4.3%. Explore profitability and growth together.

Ask for details

Company Overview

TCI Gene Inc. is a biotechnology company specializing in the development and manufacturing of gene testing, stem cell, and immune cell products. Its core services include precision genetic testing for health-related traits such as nutrient metabolism and weight management, virus detection, and cell-based experiments. The company also offers stem cell therapies, natural killer cell production, and personalized healthcare products, including nutrition supplements and gene-targeted health foods. Additionally, TCI Gene Inc. provides skincare, antiaging solutions, and specialized products for children’s growth and neurodegenerative disease support. By combining advanced R&D capabilities with customized health management solutions, TCI Gene Inc. plays a vital role in supporting preventive medicine and personal wellness within the healthcare sector. Established in 2011 and based in Taipei, it contributes to the integration of biotechnology with individualized healthcare, reinforcing the growing significance of precision medicine in regional and global markets.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$273.61MRevenue
0.00Shares Out
0Employees

Margins

55.77%Gross
18.45%EBITDA
6.97%Operating
14.24%Pre-Tax
14.28%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-13.59%Rev 3Yr
7.24%Rev 5Yr
-40.62%Op Inc 3Yr
-16.34%Op Inc 5Yr
-19.29%Net Inc 3Yr
1.76%Net Inc 5Yr

Returns

3.70%ROA
4.35%ROE
3.83%ROIC

Financial Health

NT$250.69MCash & Cash Equivalents
NT$-152.04MNet Debt
10.81%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

TCI Gene Inc. (ticker: 6879) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 37 with a P/E ratio of -x and P/B of -x.

ROE is 4.35% and operating margin is 6.97%. Annual revenue is $274M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
TCI Gene Inc. (6879) Stock Forecast 2026 $37.00 — Price, Financials & Analyst Targets | Alpha Lenz